Rectal cancer radiotherapy
- PMID: 17620771
- DOI: 10.1097/PPO.0b013e318074def2
Rectal cancer radiotherapy
Abstract
Adjuvant therapy for rectal cancer has undergone significant modifications over the past 30 years, including the addition of radiation therapy, significant improvements in surgical technique, and the administration of systemic therapy. Historically, curative resection commonly required an abdominoperineal resection and permanent colostomy. Adjuvant radiation therapy not only improved local control and overall survival, but allowed the opportunity for sphincter-preserving resections in patients with adequate sphincter function and tumors located approximately 1-2 cm from the dentate line. Local recurrence, a primary mode of failure in rectal cancer, has been improved by the development of the total mesorectal excision, with en-bloc resection of the rectum and its lymphovascular mesentery, the mesorectum. Removing micrometastatic disease within the mesorectum has also enhanced sphincter preservation without compromising local control or survival. Locoregional recurrence has remained a significant issue for patients with locally advanced disease (node positive or high T stage). Multiple studies have shown that the addition of chemotherapy further improves outcomes versus surgery alone or combined surgery and radiation, due both to the radiosensitizing properties of certain systemic agents as well as to the direct cytotoxic effect of the chemotherapy on micrometastatic disease. Adjuvant concurrent chemoirradiation in locally advanced rectal cancer confers a significant improvement in local control and overall survival compared with either modality alone. The future direction of treatment for rectal cancer will certainly consist of improved imaging and other diagnostic techniques to determine more accurately the need for adjuvant therapy. Multimodality therapy with radiotherapy administered in combination with systemic and biologic agents as radiation sensitizers is currently under investigation and may allow for improved local control and perhaps allow for minimizing the extent of surgery in selected situations.
Similar articles
-
Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.Jpn J Clin Oncol. 2008 Feb;38(2):112-21. doi: 10.1093/jjco/hym164. Epub 2008 Feb 8. Jpn J Clin Oncol. 2008. PMID: 18263881
-
Multimodality management of locally advanced rectal cancer.Am Surg. 2003 Jul;69(7):612-9. Am Surg. 2003. PMID: 12889627 Review.
-
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.J Clin Oncol. 2004 Jan 1;22(1):166-74. doi: 10.1200/JCO.2004.04.172. J Clin Oncol. 2004. PMID: 14701779
-
Laparoscopic intersphincteric resection for low rectal cancer.Surg Oncol. 2007 Dec;16 Suppl 1:S117-20. doi: 10.1016/j.suronc.2007.10.006. Epub 2007 Nov 26. Surg Oncol. 2007. PMID: 18023571
-
[Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].Gan To Kagaku Ryoho. 2007 Oct;34(10):1553-6. Gan To Kagaku Ryoho. 2007. PMID: 17940371 Review. Japanese.
Cited by
-
Urinary adverse effects of pelvic radiotherapy.Transl Androl Urol. 2014 Jun;3(2):186-95. doi: 10.3978/j.issn.2223-4683.2014.04.01. Transl Androl Urol. 2014. PMID: 26813159 Free PMC article. Review.
-
Long-term urinary adverse effects of pelvic radiotherapy.World J Urol. 2011 Feb;29(1):35-41. doi: 10.1007/s00345-010-0603-x. Epub 2010 Oct 20. World J Urol. 2011. PMID: 20959990 Free PMC article. Review.
-
Short-course versus long-course neoadjuvant radiotherapy for lower rectal cancer: a systematic review.Ir J Med Sci. 2010 Jun;179(2):165-71. doi: 10.1007/s11845-009-0382-9. Epub 2009 Jun 30. Ir J Med Sci. 2010. PMID: 19565313
-
The effect of adjuvant chemoradiotherapy on survival after R0 resection for stage III-N2 nonsmall cell lung cancer: A meta-analysis.Medicine (Baltimore). 2022 Jul 15;101(28):e29580. doi: 10.1097/MD.0000000000029580. Medicine (Baltimore). 2022. PMID: 35839033 Free PMC article.
-
Total Mesorectal Excision vs. Transanal Endoscopic Microsurgery Followed by Radiotherapy for T2N0M0 Distal Rectal Cancer: A Multicenter Randomized Trial.Front Surg. 2022 Feb 1;9:812343. doi: 10.3389/fsurg.2022.812343. eCollection 2022. Front Surg. 2022. PMID: 35178428 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous